Suppr超能文献

聚乙二醇4000对左结肠运动活性24小时压力记录的影响。

Effects of polyethylene glycol 4000 on 24-h manometric recordings of left colonic motor activity.

作者信息

Herve S, Leroi A M, Mathiex-Fortunet H, Garnier P, Karoui S, Menard J F, Ducrotte P, Denis P

机构信息

Groupe de Recherche de l'Appareil Digestif Environnement et Nutrition, Hĵpital Charles Nicolle, Rouen, France.

出版信息

Eur J Gastroenterol Hepatol. 2001 Jun;13(6):647-54. doi: 10.1097/00042737-200106000-00006.

Abstract

BACKGROUND

It has been shown that low doses of polyethylene glycol (PEG) 4000 are effective in the treatment of chronic constipation. The aim of this study was to describe the effects on colonic motility of oral PEG 4000 treatment and intraluminal instillation of PEG 4000.

METHODS

Left colonic and rectosigmoid manometric recordings were performed for 27 h in six constipated patients and in six healthy volunteers. At the end of the recording, bisacodyl and PEG 4000 were instilled into the lumen of the colon. To assess the effects of oral administration of PEG 4000 on colonic motility, manometric recordings were also performed in constipated patients after 4 weeks of treatment with PEG 4000.

RESULTS

All patients had significantly more stools during than before PEG treatment. There was no significant difference between the number and the characteristics of high-amplitude propagating contractions (HAPC) or the area under the curve (AUC) before or during treatment with PEG 4000. Intraluminal instillation of PEG induced HAPC in only one patient and in no controls.

CONCLUSION

This study shows that PEG 4000 has no effect on left colonic and rectosigmoid motor activity during oral treatment, despite its clinical effectiveness, or after local instillation.

摘要

背景

已表明低剂量聚乙二醇(PEG)4000对慢性便秘的治疗有效。本研究的目的是描述口服PEG 4000治疗和结肠腔内注入PEG 4000对结肠动力的影响。

方法

对6名便秘患者和6名健康志愿者进行27小时的左结肠和直肠乙状结肠测压记录。记录结束时,将比沙可啶和PEG 4000注入结肠腔。为评估口服PEG 4000对结肠动力的影响,在PEG 4000治疗4周后的便秘患者中也进行了测压记录。

结果

所有患者在PEG治疗期间的排便次数均明显多于治疗前。在PEG 4000治疗前或治疗期间,高振幅传播收缩(HAPC)的数量和特征或曲线下面积(AUC)之间无显著差异。仅1例患者在结肠腔内注入PEG后诱发了HAPC,对照组未出现。

结论

本研究表明,尽管PEG 4000具有临床疗效,但口服治疗期间或局部注入后,其对左结肠和直肠乙状结肠的运动活性均无影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验